December 15, 2016 / 1:15 PM / 8 months ago

BRIEF-Baxter International to buy Claris Injectables Limited

Dec 15 (Reuters) - Baxter International Inc

* Baxter international inc - deal for total consideration of approximately $625 million

* Baxter international inc says upon closing, deal is expected to be modestly accretive to adjusted earnings and increasingly accretive thereafter

* Deal expected to close in second half of 2017

* Baxter international inc - anticipates launching seven to nine new products annually over next few years

* Baxter international inc - total consideration of approximately $625 million

* Baxter international inc - boards of directors of both companies have approved proposed acquisition, which is expected to close in second half of 2017

* Baxter international inc says in 2016, claris injectables is expected to deliver annual global revenues in excess of $100 million

* Baxter international inc says expects to finance transaction through cash on hand, debt or a combination

* Baxter to expand portfolio of essential generic injectable medicines with acquisition of claris injectables limited Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below